← ANALYST RATINGS · TIPRANKS

UnitedHealth (UNH): analyst forecast and price target

$401 −1.29% close 16.10.26 · market cap $365B · Healthcare · Medical - Healthcare Plans SPY 0.53%
Price targets and ratings of

Analyst consensus

Strong Buy

14 Buy4 Hold0 Sell

Ratings of 18 analysts in the last 3 months

12-month forecast

$483+20.4% upside

Based on 18 price targets given in the last 3 months, the average target is $483, the highest $529, the lowest $402. The average is +20.4% from the last price of $401.

$300$400$500Jan 26AprJulOctJan 27AprJulOctHigh$529Average$483Low$402
Highest target $529 Average target $483 Lowest target $402
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $516 → $524+1.6% Buy +30.5% Assigned 16.10.26on TipRanks 07:40 −0.2%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $512 → $500−2.3% Buy +24.6% Reiterated 16.10.26on TipRanks 06:25 −0.2%
Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% Raymond James $475 → $450−5.3% Buy +12.1% Reiterated 15.10.26on TipRanks 09:30 +2.5%next day −0.2%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $402 Hold +0.1% Reiterated 15.10.26on TipRanks 08:50 +2.5%next day −0.2%
Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% Leerink Partners $472 Buy +17.6% Assigned 14.10.26on TipRanks 09:12 +5.8%next day +2.5%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $453 → $427−5.7% Hold +6.4% Reiterated 14.10.26on TipRanks 07:30 +5.8%next day +2.5%
Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% Piper Sandler $502 → $504+0.4% Buy +25.6% Reiterated 14.10.26on TipRanks 06:55 +5.8%next day +2.5%
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $468 → $529+13.0% Buy +31.8% Reiterated 14.10.26on TipRanks 06:30 +5.8%next day +2.5%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $441 → $440−0.2% Buy +9.6% Reiterated 14.10.26on TipRanks 05:01 +5.8%next day +2.5%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $490 → $506+3.3% Buy +26.0% Reiterated 13.10.26on TipRanks Oct 14 08:30 −0.2%next day +5.8%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $512 Buy +27.5% Reiterated 13.10.26on TipRanks Oct 14 05:26 −0.2%next day +5.8%
Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% Evercore ISI $480 Buy +19.6% Reiterated 13.10.26on TipRanks 10:05 −0.2%next day +5.8%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $490 Buy +22.1% Reiterated 12.10.26on TipRanks Oct 13 01:16 −0.1%next day −0.2%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $430 → $402−6.5% Hold +0.1% Reiterated 09.10.26on TipRanks 08:35 +1.7%next day −0.1% · 5 days +7.8%
Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% Piper Sandler $475 → $463−2.5% Buy +15.3% Reiterated 09.10.26on TipRanks 07:40 +1.7%next day −0.1% · 5 days +7.8%
Hans Engel★★★★★★★★★★#1835 · hits 58% · avg +11.1% Erste Group — Hold — Reiterated 08.10.26on TipRanks 06:55 −0.9%next day +1.7% · 5 days +9.9%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $478 Buy +19.1% Reiterated 07.10.26on TipRanks Oct 8 21:45 +0.1%next day −0.9% · 5 days +6.2%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $512 Buy +27.5% Reiterated 05.10.26on TipRanks 07:31 +1.1%next day −1.1% · 5 days −0.4%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $490 Buy +22.1% Reiterated 02.10.26on TipRanks Oct 5 09:35 +1.1%next day +1.1% · 5 days +0.8%
Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% Wells Fargo $526 Buy +31.0% Reiterated 15.09.26on TipRanks 07:25 −1.5%next day +0.3% · 5 days −3.2%
Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% Evercore ISI $480 Buy +19.6% Reiterated 14.09.26on TipRanks 09:15 +2.2%next day −1.5% · 5 days −3.5%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $490 Buy +22.1% Reiterated 14.09.26on TipRanks 05:45 +2.2%next day −1.5% · 5 days −3.5%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $441 Buy +9.9% Reiterated 10.09.26on TipRanks 05:36 −0.6%next day −3.2% · 5 days −3.4%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $512 Buy +27.5% Reiterated 09.09.26on TipRanks 06:35 −1.5%next day −0.6% · 5 days −2.8%
Hans Engel★★★★★★★★★★#1835 · hits 58% · avg +11.1% Erste Group — Hold — Downgrade 27.08.26on TipRanks 12:00 −2.1%next day −0.3% · 5 days +1.2%
George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% Deutsche Bank — Hold — Reiterated 03.08.26on TipRanks 09:55 −1.2%next day −3.7% · 5 days −3.6%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $466 → $516+10.7% Buy +28.5% Reiterated 21.07.26on TipRanks Jul 24 05:11 +2.7%next day −1.0% · 5 days −0.7%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $470 → $493+4.9% Buy +22.8% Reiterated 21.07.26on TipRanks Jul 24 05:11 +2.7%next day −1.0% · 5 days −0.7%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $430 Hold +7.1% Reiterated 19.07.26on TipRanks Jul 24 05:11 −0.9%next day +2.7% · 5 days −0.5%
David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% Argus Research $400 → $470+17.5% Buy +17.1% Reiterated 17.07.26on TipRanks Jul 24 05:11 +1.6%next day −0.9% · 5 days −0.7%
Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% Leerink Partners — Buy — Reiterated 17.07.26on TipRanks Jul 19 10:23 +1.6%next day −0.9% · 5 days −0.7%
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $468 → $529+13.0% Buy +31.8% Assigned 17.07.26on TipRanks 06:30 +1.6%next day −0.9% · 5 days −0.7%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $475 → $512+7.8% Buy +27.5% Reiterated 17.07.26on TipRanks 05:15 +1.6%next day −0.9% · 5 days −0.7%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $287 → $453+57.8% Hold +12.8% Upgrade 17.07.26on TipRanks Jul 16 13:00 +1.7%next day +1.6% · 5 days +1.7%
Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% Oppenheimer $420 → $500+19.0% Buy +24.6% Assigned 17.07.26on TipRanks Jul 16 08:15 +1.7%next day +1.6% · 5 days +1.7%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial $480 → $500+4.2% Buy +24.6% Reiterated 17.07.26on TipRanks Jul 14 07:55 −1.3%next day −2.0% · 5 days +3.1%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $400 → $490+22.5% Buy +22.1% Assigned 16.07.26on TipRanks Jul 17 08:10 +1.7%next day +1.6% · 5 days +1.7%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $463 → $478+3.2% Buy +19.1% Reiterated 16.07.26on TipRanks Jul 17 07:15 +1.7%next day +1.6% · 5 days +1.7%
Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% Piper Sandler $420 → $475+13.1% Buy +18.3% Reiterated 15.07.26on TipRanks 13:30 −2.0%next day +1.7% · 5 days +4.0%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc $400 → $475+18.8% Buy +18.3% Reiterated 14.07.26on TipRanks 04:41 −1.3%next day −2.0% · 5 days +3.1%
Sidharth Sahoo★★★★★★★★★★#9090 · hits 43% · avg −0.9% HSBC $300 → $380+26.7% Hold −5.3% Reiterated 06.07.26on TipRanks 10:35 −2.6%next day +2.9% · 5 days +2.9%
John Ransom★★★★★★★★★★#681 · hits 60% · avg +10.2% Raymond James $330 → $370+12.1% Buy −7.8% Reiterated 22.04.26on TipRanks 10:30 +1.2%next day +0.7% · 5 days +4.8%
David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% Jefferies $340 → $373+9.7% Buy −7.1% Reiterated 20.04.26on TipRanks 06:35 −0.2%next day +7.6% · 5 days +8.7%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $440 Buy +9.6% Reiterated 28.01.26on TipRanks 07:20 +4.0%next day −0.4% · 5 days −4.8%
Justin Lake★★★★★★★★★★#1616 · hits 68% · avg +12.7% Wolfe Research $363 → $330−9.1% Buy −17.8% Reiterated 27.10.25on TipRanks Oct 28 08:35 −0.2%next day +0.2% · 5 days −8.5%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering UnitedHealth

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months A.J. Rice★★★★★★★★★★UBS · #690
Hits 61%298 of 485 Average return +9.8%
1 year Scott Fidel★★★★★★★★★★Goldman Sachs · #1346
Hits 64%178 of 279 Average return +7.9%
2 years A.J. Rice★★★★★★★★★★UBS · #690
Hits 61%298 of 485 Average return +9.8%

Most profitable

3 months A.J. Rice★★★★★★★★★★UBS · #690
Hits 61%298 of 485 Average return +9.8%
1 year A.J. Rice★★★★★★★★★★UBS · #690
Hits 61%298 of 485 Average return +9.8%
2 years David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $482 at a price of $367 (+31.2%); now: $483 at $401 (+20.4%).

$400$450$500Sep 15Oct 1Oct 15Top analysts$500Average target$483Price$401

PriceAverage targetTop analysts’ target

Recommendation trend

02040605292Oct 254781Nov3551Dec292Jan 26303Feb1273Mar12981Apr13281May4081Jun345Jul286Aug276Sep246Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy100000
Buy324034282724
Hold885666
Sell110000

Earnings and sales forecast

Next report: 20.01.27 (Q4 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.27 (from $2.09 to $2.62). Last quarter: $4.69.

Sales

Next quarter’s sales estimate — $112.1B (from $109.1B to $115.4B). Last quarter: $112.7B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About UnitedHealth

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy,

Data from the stock’s TipRanks forecast page, read 2 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗